PT - JOURNAL ARTICLE AU - Penda Johm AU - Oluwatosin Nkereuwem AU - Aji-Matty Manjang AU - Omar Ceesay AU - Lamin Leigh AU - Amie Ceesay AU - Mustapha Bittaye AU - Adeyemi Roberts AU - Buba Manjang AU - Sana Sambou AU - Sainey Sanneh AU - Lamin Saidy AU - Binta Saidy AU - Beate Kampmann TI - COVID-19 Health Care Behaviour in The Gambia: a cross-sectional survey of 205 adults who went through mandatory institutional quarantine AID - 10.1101/2021.11.17.21266451 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.17.21266451 4099 - http://medrxiv.org/content/early/2021/11/21/2021.11.17.21266451.short 4100 - http://medrxiv.org/content/early/2021/11/21/2021.11.17.21266451.full AB - Background To control the spread of the novel Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome novel Coronavirus-2 (SARS-CoV-2), countries around the world subsequently implemented several public health measures, including the adoption of mandatory institutional quarantine for close contacts. This study explored the experiences of individuals who underwent institutional quarantine in The Gambia to inform government measures to increase its effectiveness and reduce its associated negative impacts.Methods Questionnaires were administered via mobile phone call with data collectors calling and directly recording participant responses on a tablet in an electronic online form developed in REDCap (Research Electronic Data Capture). The questionnaire contained questions on COVID-19 related knowledge, health care behaviour, attitudes, perceptions and stigma. Data were analysed using STATA v.13 (Stata Corp, College Station, TX, USA).Results In total, 205 adults who observed the mandatory institutional quarantine were interviewed. There was varied knowledge of COVID-19 causes, spread, symptoms, diagnosis, treatment, and severity. Participants believed the purpose of quarantine was monitoring for signs and symptoms of coronavirus disease, testing for SARS-CoV-2, separation from the community, and protection from coronavirus disease. While a majority reported positive experiences while in quarantine, some expressed prominent dissatisfaction related to the essential services and quality of care provided. Different forms of stigma were also experienced before, during and after the quarantine experience.Conclusion This study provides important information on quarantine experiences in The Gambia during the global COVID-19 pandemic. The Ministry of Health in The Gambia and other countries could improve the experience of quarantined individuals by consistently providing psychosocial support, compensation for loss of earnings, and timely provision of SARS-CoV-2 test results. Furthermore, stigma experiences and practices should be addressed during and after individuals stay in quarantine via the provision of psychosocial support.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this study. However, data collection activities were funded from discretional MRCG@LSHTM funds awarded to BK. The funders had no role in the design of the study, collection, analysis, and/or interpretation of data and in writing the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Gambia Government/MRC Joint Ethics Committee (Ref. 22271) on the 11th of August 2020. The London School of Hygiene & Tropical Medicine (LSHTM) Observational/Interventions Research Ethics Committee (Ref. 22271) on the 17th of August 2020.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.AoUAssessment of UnderstandingANCAntenatal careCDCCentres for Disease Control and PreventionCOVID-19Coronavirus disease 2019GDHSGambia Demographic and Health SurveyHSBHealth seeking behaviourMICSMultiple Indicator Cluster SurveyMoHMinistry of HealthMRCG at LSHTMMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical MedicinePASSPartners for Applied Social SciencesREDCapResearch Electronic Data CaptureSARS-Cov-2Severe Acute Respiratory Syndrome Novel Coronavirus-2WHOWorld Health Organization